Literature DB >> 27513765

Clinical Considerations for Vascularized Composite Allotransplantation of the Eye.

Edward H Davidson1, Eric W Wang, Jenny Y Yu, Juan C Fernandez-Miranda, Dawn J Wang, Yang Li, Maxine Miller, Wesley N Sivak, Debra Bourne, Hongkun Wang, Mario G Solari, Joel S Schuman, Kia M Washington.   

Abstract

Vascularized composite allotransplantation represents a potential shift in approaches to reconstruction of complex defects resulting from congenital differences as well as trauma and other acquired pathology. Given the highly specialized function of the eye and its unique anatomical components, vascularized composite allotransplantation of the eye is an appealing method for restoration, replacement, and reconstruction of the nonfunctioning eye. Herein, we describe conventional treatments for eye restoration and their shortcomings as well as recent research and events that have brought eye transplantation closer to a potential clinical reality. In this article, we outline some potential considerations in patient selection, donor facial tissue procurement, eye tissue implantation, surgical procedure, and potential for functional outcomes.

Entities:  

Mesh:

Year:  2016        PMID: 27513765      PMCID: PMC5342906          DOI: 10.1097/SCS.0000000000002985

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  63 in total

1.  Vision therapy. Information for health care and other allied professionals. A Joint Organizational Policy Statement of the American Academy of Optometry and the American Optometric Association.

Authors: 
Journal:  J Am Optom Assoc       Date:  1999-07

2.  Vascularized composite allotransplantation: a member of the transplant family?

Authors:  Stefan Schneeberger; Emmanuel Morelon; Luis Landin
Journal:  Transplantation       Date:  2012-06-15       Impact factor: 4.939

3.  Restoration of electroretinogram activity in exenterated swine eyes following ophthalmic artery anastomosis.

Authors:  Jun Shi; David Ellenberg; Jae Yong Kim; Haohua Qian; Harris Ripps; Sandeep Jain; Jin-Hong Chang; Dimitri T Azar
Journal:  Restor Neurol Neurosci       Date:  2009       Impact factor: 2.406

4.  Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.

Authors:  Joseph Leventhal; Michael Abecassis; Joshua Miller; Lorenzo Gallon; Kadiyala Ravindra; David J Tollerud; Bradley King; Mary Jane Elliott; Geoffrey Herzig; Roger Herzig; Suzanne T Ildstad
Journal:  Sci Transl Med       Date:  2012-03-07       Impact factor: 17.956

5.  A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.

Authors:  Cheryl A Arcinue; Olga M Cerón; C Stephen Foster
Journal:  J Ocul Pharmacol Ther       Date:  2013-01-08       Impact factor: 2.671

6.  Management of traumatic luxation of the globe. A case report.

Authors:  H Kiratli; B Tümer; S Bilgiç
Journal:  Acta Ophthalmol Scand       Date:  1999-06

7.  Total eye transplantation for the blind: a challenge for the future.

Authors:  S Canavero
Journal:  Med Hypotheses       Date:  1992-11       Impact factor: 1.538

Review 8.  Critical period revisited: impact on vision.

Authors:  Hirofumi Morishita; Takao K Hensch
Journal:  Curr Opin Neurobiol       Date:  2008-06-03       Impact factor: 6.627

9.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

10.  Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model.

Authors:  Yur-Ren Kuo; Shigeru Goto; Hsiang-Shun Shih; Feng-Sheng Wang; Chien-Chih Lin; Chun-Ting Wang; Eng-Yen Huang; Chao-Long Chen; Fu-Chan Wei; Xin Xiao Zheng; W P Andrew Lee
Journal:  Transplantation       Date:  2009-06-27       Impact factor: 4.939

View more
  4 in total

1.  Total Human Eye Allotransplantation: Developing Surgical Protocols for Donor and Recipient Procedures.

Authors:  Edward H Davidson; Eric W Wang; Jenny Y Yu; Juan C Fernandez-Miranda; Dawn J Wang; Nikisha Richards; Maxine Miller; Joel S Schuman; Kia M Washington
Journal:  Plast Reconstr Surg       Date:  2016-12       Impact factor: 4.730

2.  In vivo MRI evaluation of anterograde manganese transport along the visual pathway following whole eye transplantation.

Authors:  Chiaki Komatsu; Yolandi van der Merwe; Lin He; Anisha Kasi; Jeffrey R Sims; Maxine R Miller; Ian A Rosner; Neil J Khatter; An-Jey A Su; Joel S Schuman; Kia M Washington; Kevin C Chan
Journal:  J Neurosci Methods       Date:  2022-02-22       Impact factor: 2.390

3.  Rejection of Acellular Porcine Corneal Stroma Transplantation During Coronavirus Disease 2019 Pandemic.

Authors:  Li-Na Chen; Ji-Long Hao; Xiu-Fen Liu; Dan-Dan Zhou; Om Prakash Pant; Xiang-Yu Liu; Hui-Feng Liu; Hong-Wei Liu; Cheng-Wei Lu
Journal:  J Craniofac Surg       Date:  2021-10-27       Impact factor: 1.172

4.  Adipose-derived stromal cells modulating composite allotransplant survival is correlated with B cell regulation in a rodent hind-limb allotransplantation model.

Authors:  Chien-Chang Chen; Rong-Fu Chen; Jheng-Syuan Shao; Yun-Ting Li; Yu-Chi Wang; Gerald Brandacher; Jiin-Haur Chuang; Yur-Ren Kuo
Journal:  Stem Cell Res Ther       Date:  2020-11-11       Impact factor: 6.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.